Clínica Médica
Perspectiva | As evidências sobre a 4ª dose das vacinas contra Covid & a questão complicada dos limites de idade.
6 Abr, 2022 | 12:53hConteúdos relacionados:
U.S. approves second Covid-19 booster for people 50 and older and immunocompromised individuals.
[Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.
Covid-19: Fourth vaccine doses—who needs them and why?
[Not published yet] Study in Israel finds fourth COVID booster has limited efficacy.
Comentário no Twitter
The evidence on 4th doses of Covid vaccines & the thorny question of age thresholds – 50? 55? 60? 65? 70? 75? 80? Each has been set by at least one country… | New @PLOS https://t.co/4tJ0o1fUC1
— Hilda Bastian, PhD (@hildabast) April 1, 2022
Estudo de coorte | Níveis séricos elevados de sódio na meia-idade (pode haver correlação com baixa ingestão hídrica) estão associados a risco aumentado de hipertrofia ventricular e insuficiência cardíaca após 25 anos de seguimento.
6 Abr, 2022 | 12:51hMiddle age serum sodium levels in the upper part of normal range and risk of heart failure – European Heart journal (link para o resumo – $ para o texto completo)
Comunicado de imprensa: Good hydration may reduce long-term risks for heart failure – Serum sodium levels may help identify adults with a greater chance of experiencing heart disease. – National Institutes of Health
Opinião | Cannabis medicinal para dor crônica: o triângulo das Bermudas dos estudos de baixa qualidade, incontáveis metanálises e recomendações conflitantes.
6 Abr, 2022 | 12:49hConteúdos relacionados:
M-A: Birth outcomes of neonates exposed to marijuana in utero.
Cannabis-related allergies: an international overview and consensus recommendations.
Review: Cannabis-based medicines and medical cannabis for chronic neuropathic pain.
Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain.
Cannabis products are being sold as sleep remedies – here’s the evidence about their effectiveness.
Guideline: Medical cannabis or cannabinoids for chronic pain.
NICE Guideline: Cannabis-Based Medicinal Products
Short Review: Drug Interactions with Cannabinoids
Meta-Analysis: Cannabinoids Not Effective for Cancer-Related Pain
Review: Considerations for cannabinoids in perioperative care by anesthesiologists.
Review: Cannabis-based Medicines and the Perioperative Physician
Perspective: If You Smoke Pot, Your Anesthesiologist Needs To Know
Estudo de coorte | Mudança nas taxas de mortalidade por doença cardíaca e AVC antes e durante a pandemia de Covid-19.
6 Abr, 2022 | 12:46hComentários:
Several-Fold Increase in Stroke and Heart Disease Deaths During COVID-19 Pandemic – NeurologyToday
2019 to 2020 Saw Risk-Linked Deaths From Heart Disease, Stroke Up – HealthDay
Comentário do autor no Twitter (fio – clique pra saber mais). Artigo e imagens sob CC-BY License
Our paper @JAMANetworkOpen Sidney et al. https://t.co/bfCX9akd6p 2019 – 2020, several-fold ⬆️ in risk-associated deaths from Heart Disease & Stroke, with greater ⬆️ minorities & highest ⬆️among Black adults. More evidence of underlying systemic inequities & structural racism 🧵 pic.twitter.com/goQgPmRU9c
— Jamal Rana, MD (@JamalRanaMD) March 23, 2022
Guia prático EHRA | Como usar dispositivos digitais para detectar e tratar arritmias.
6 Abr, 2022 | 12:44hHow to use digital devices to detect and manage arrhythmias: an EHRA practical guide – EP Europace
Comunicado de imprensa: Advice on how to use digital devices to detect and manage arrhythmias published today – European Society of Cardiology
Revisão | Terapia antiplaquetária após intervenção coronariana percutânea.
6 Abr, 2022 | 12:39hAntiplatelet therapy after percutaneous coronary intervention – EuroIntervention
Comentário no Twitter
ANTIPLATELET THERAPY AFTER PCI: A State-of-the-Art review that summarises the evidence, and discuss current and future directions of antiplatelet treatment regimens after percutaneous coronary intervention. https://t.co/JyjvRTCz5e pic.twitter.com/T05SVBCmSb
— EuroIntervention (@EuroInterventio) April 1, 2022
Estudo randomizado | Eficácia e segurança do daprodustate (medicamento oral) para tratar anemia na doença renal crônica em pacientes dialíticos.
6 Abr, 2022 | 12:35hConteúdos relacionados:
Comentário no Twitter
In this RCT, daprodustat was noninferior to darbepoetin alfa in treating anemia of chronic kidney disease. Daprodustat represents an oral alternative treatment to a conventional erythropoiesis-stimulating agent in the incident dialysis population. https://t.co/uoYOcpSam6
— JAMA Internal Medicine (@JAMAInternalMed) April 4, 2022
M-A | Eficácia de intervenções para reduzir o tratamento de longo prazo com opioides para dor crônica não oncológica.
6 Abr, 2022 | 12:32hPodcast | Dicas sobre pancreatite aguda.
6 Abr, 2022 | 12:31h#327 Acute Pancreatitis – The Curbsiders
Revisão | A perspectiva do intensivista sobre choque, gerenciamento de volume e monitoramento hemodinâmico.
6 Abr, 2022 | 12:28h
Comentário no Twitter
Fluid therapy is a leading management strategy in patients with hypovolemic & distributive shock. This Critical Care Nephrology and Acute Kidney Injury article reviews hemodynamic monitoring approaches to assessing fluid responsiveness & fluid tolerance https://t.co/7Rh0DGtgRM pic.twitter.com/t8ZNXJTszn
— CJASN (@CJASN) April 4, 2022


